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1. Introduction 
It is the purpose of this review to describe several 
well characterized proteases present in tissues and 
cells which appear to be related to the pancreatic 
serine proteases. Much of the early work concerning 
the nature of tissue proteases was done during the 
late 19th century by German physiologists who were 
studying tissue autolysis [ 11. Hedin and Rowland [2] 
examined homogenates of various mammalian organs 
for proteolytic activity and observed that, with the 
exception of muscle, autolysis was greatest at acid pH. 
The term ‘cathepsin’ was introduced by Willsttitter 
and Bamann [3] in 1929 to describe proteolytic activ- 
ity of tissues in the weakly acid pH range. In recent 
years, however, this term has sometimes been applied 
to include tissue proteases in general, such as cathepsin 
G which has an optimum activity at pH 8 and 
cathepsin E which is most active at pH 2.5. The rapidly 
growing literature dealing with tissue and cellular pro- 
teases has been recently reviewed by Barrett [4]. 
respiratory and gastrointestinal diseases [4]. Malig- 
nant tissues also show significant changes in proteo- 
lytic activity compared to normal, particularly that 
due to collagenases [111. 
As important as abnormal proteolytic activity in 
tissues may be in disease states, intra- and extracellular 
proteases are necessary for maintaining normal tissue 
homeostasis. The steady-state concentration of pro- 
teins in cells and tissues is controlled by the rates of 
their synthesis and degradation [ 12,131 and although 
lysosomal proteases play a major role in intracellular 
protein degradation [ 141, there is considerable 
evidence that other proteases are of equal impor- 
tance [15]. 
Tissue and cellular serine proteases, which are 
most active at the physiological pH (pH 7-8), have 
been implicated in such processes as cellular chem- 
otaxis [5], endocytosis, exocytosis [6], protein tum- 
over in tissues [4,7] tumorigenesis [8] and fertiliza- 
tion [9], but very few of these enzymes have been 
purified or characterized in detail. Two notable 
exceptions are the human neutrophil serine proteases, 
cathepsin G, and elastase which have been intensely 
studied because of their implication in emphysema 
and other respiratory [lo] disorders. Imbalances in 
the levels or regulation of tissue and cellular protease 
are generally thought to manifest themselves in 
various disease states, e.g., muscular dystrophy, 
arthritis, degenerative skin disorders as well as certain 
Several hypotheses have been advanced suggesting 
that specific limited proteolysis initiates the degrada- 
tion of certain intracellular or extracellular proteins 
or groups of similar proteins [15,16]. For example, 
mammalian collagenases, secreted by several types of 
connective tissue cells exhibit specific and limited 
activity and so do the cytoplasmic proinsulin 
degrading proteases [ 171. Support for the existence 
of intracellular degradative pathways of this type was 
derived from the investigations of Katunuma and 
coworkers [ 181 who have isolated several proteases 
exhibiting relatively restricted specificities and 
optimal activities at pH 8-9. It was reported that 
these proteases inactivated by limited proteolysis the 
apo-forms of pyridoxal phosphate dependent enzymes 
but not those requiring other cofactors [ 191. These 
intracellular ‘group-specific’ proteases were shown to 
possess chymotrypsin-like specificity toward small 
synthetic substrates, were inactivated by DFP, sug- 
gesting that their catalytic sites were structurally 
related to those of the pancreatic serine proteases 
[ 191. Because of the increasing awareness of the role 
ElsevierjNorth-Holland Biomedical Press 189 
Volume 114, number 2 FEBS LETTERS 
of limited proteolysis in many biological control 
mechanisms [20] and in tissue homeostasis [4,21], 
we have studied in detail the nature of these group- 
specific proteases of rat tissues. Some of our findings 
were unexpected while others emphasize the difficul- 
ties in attempting to interpret cellular events on the 
basis of observations made using tissue homogenates. 
Wherever appropriate we shall relate our findings 
about the nature of these enzymes to those which 
have been described for the other well characterized 
tissue serine proteases; i.e., neutrophil cathepsin G 
and elastase. 
cells of the intestinal mucosa [26]. Cells containing 
the protease were observed in the bronchial and 
tracheal mucosa as well. 
2. Purification 
Katunuma and coworkers [ 19,22,23] describe the 
purification and characterization of four similar but 
distinct ‘group-specific’ proteases from rat tissue; two 
from the small intestine (one from mucosa and the 
other reported to originate in the smooth muscle 
layer) and one each from skeletal muscle and liver. 
The liver protease was thought to be a mitochondrial 
enzyme [ 191 on the basis of determinations of marker 
enzyme levels of fractions obtained by differential 
centrifugation. We decided to study the proteases 
from the muscle layer of small intestine and from 
skeletal muscle since these enyzmes could be obtained 
in sufficient quantity to allow detailed chemical 
characterization. Affinity chromatographic methods 
were developed in order to purify the proteases more 
efficiently and rapidly than previously possible. 
A similar chymotrypsin-like protease, known as 
chymase, is present in mast cells obtained from rat 
peritoneum [27]. The amino acid composition 
(table 1) of this enzyme is clearly different from that 
of the atypical mast cell protease, but it is remarkably 
similar to that of the skeletal muscle protease [28]. 
The amino-terminal sequences of the mast cell pro- 
tease and the skeletal muscle protease are identical 
for the first 35 residues [28]. Immunodiffusion tests 
for cross-reactivity using anti-rat mast cell protease 
indicated that the mast cell and skeletal muscle 
proteases are immunologically identical [28]. Finally, 
immunofluorescent localization of skeletal muscle 
protease showed that this enzyme was in fact derived 
from mast cells present in the connective tissue of 
muscle (N. Katunuma, personal communication). 
Thus, both of these ‘group-specific’ proteases are in 
fact derived from mast cells. 
Several other investigators have isolated chymo- 
trypsin-like serine proteases from a variety of rat 
Comparison of the amino acid compositions of rat mast 
cell proteases 
Amino 
acid 
The immobilized ligands were potato chymotrypsin 
inhibitor I immobilized on Sepharose 4B for the puri- 
fication of the intestinal protease [24] and ovoin- 
hibitor coupled to Sepharose 4B for the rat skeletal 
muscle protease [25]. The proteases isolated by these 
methods were chemically, physically, enzymatically 
and immunologically identical to those prepared by 
the described procedures [ 19,221. 
3. Localization and identification 
During the development of the affinity chromato- 
graphic purification method, it became apparent that 
the intestinal protease was not present in the muscle 
layer as reported [ 191. Immunofluorescent and 
histochemical studies revealed that, in fact, the pro- 
tease was contained in the so-called ‘atypical’ mast 
Aspartic acid 18.5 14 
Threonine 16.8 13 
Serine 12.0 13 
Glutamic acid 20.0 17 
Proline 16.2 15 
Glycine 22.4 18 
Alanine 15.6 16 
Valine 22.1 22 
Methionine 5.1 5 
Isoleucine 12.4 18 
Leucine 12.5 16 
Tyrosine 9.9 9 
Phenylalanine 8.0 6 
Histidine 8.8 9 
Lysine 22.7 13 
Arginine 13.3 12 
Half-cystine n.d. 6 
Tryptophan n.d. 2 
a Determined by analysis of samples after 24 h hydrolysis in 
6 NHClat 110°C [28] 
b From sequence analysis [ 37 ] 
n.d., Not determined 
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Table 1 
mol ammo acid/m01 protein 
RMCP la RMCP IIb 
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tissues such as skin, liver, thymus and skeletal muscle 
[29-3 11. Besides their similar esterase specificities, 
these enzymes usually require concentrated salt solu- 
tions to maintain their solubility. It has now become 
apparent that many of these proteases are derived 
from normal mast cells which are widely distributed 
in rat connective tissue [32,33]. In fact, two similar 
proteases from liver, separately reported to be mito- 
chondrial enzymes [19,34], have recently been iden- 
tified as the chymotrypsin-like protease (chymase) of 
normal mast cells [35]. Subsequently, Katunuma has 
re-evaluated his observation that homogenates of 
Morris hepatomas grown in rats have -loo-fold 
greater activity of the ‘mitochondrial’ chymotrypsin- 
like protease compared to that of normal rat liver 
[36] and has shown that the increase in enzyme activ- 
ity is due to a similar increase in the number of mast 
cells present in the hepatoma (N. Katunuma, personal 
communication). 
In recent years, much effort has been made to 
isolate and study alkaline proteases from tissues in an 
attempt to elucidate the mechanisms involved in 
intracellular and extracellular protein turnover. There 
is now abundant evidence that the rat (or other ani- 
mals containing large numbers of mast cells) should 
be avoided for such studies due to the likelihood that 
homogenates of tissues will contain significant levels 
of highly active mast cell protease. 
4. Chemical structure and evolution 
The complete covalent structure of the protease 
of atypical mast cells, RMCP II (rat mast cell protease 
II), has been determined [37]. 
The protease contains 224 amino acid residues in a 
single polypeptide chain crosslinked by three disulfide 
bonds (fig.1). A homologous relationship is clearly 
evident when this structure is compared to those of 
chymotrypsin, trypsin and elastase (-33% sequence 
identity to each). In addition, the residues forming 
the charge-relay system of the active site of chymo- 
trypsin (His-57, Asp-102, Ser-195) are found in cor- 
responding regions of the atypical mast cell protease. 
These structural features clearly indicate that the 
mast cell enzyme is structurally and mechanistically 
closely related to the pancreatic serine proteases. 
However, other structural features distinguish this 
protease from the known serine proteases. 
(1) An alanyl residue is at position 176 in the mast 
cell protease corresponding to a residue which 
1 10 
H2N-Ile-Ile-Gly-Gly-Val-Glu-Ser-Ile-Pro-His-Ser-Arg-Pro-Tyr- 
20 
Met-Ala-His-Leu-Asp-Ile-Val-Thr-Glu-Lys-Gly-Leu-Arg-Val-Ile- 
30 40 
Cys-Gly-Gly-Phe-Leu-Ile-Ser-Arg-G1n-Phe-Val-Leu-Thr-Ala-Ala- 
Lss, 50 
HIS-Cys-Lys-Gly-Arg-Glu-Ile-Thr-Val-Ile-Leu-Gly-Ala-His-Asp- 
60 70 
Val-Arg-Lys-Arg-G1u-Ser-Thr-Gln-Gln-Lys-Ile-Lys-Val-G1u-Lys- 
80 
Gln-Ile-Ile-His-G1u-Ser-Tyr-Asn-Ser-Val-Pra-Asn-Leu-His-ASP- 
90 100 
Ile-Met-Leu-Leu-Lys-Leu-Glu-Lys-Lys-Val-Glu-Leu-Thr-Pro-Ala- 
110 
Val-Asn-Val-Val-Pro-Leu-Pro-Ser-Pro-Ser-Asp-Phe-Ile-His-Pro- 
120 130 
Gly-Ala-Met-Cys-Trp-~la-Ala-Gly-Trp-Gly-Lys-Thr-Gly-Val-Arg- 
-s&---J 
140 
Asp-Pro-Thr-Ser-Tyr-Thr-Leu-Arg-Glu-Val-Glu-Leu-Arg-Ile-Met- 
150 160 
Asp-Glu-Lys-Ala-Cys-Val-Asp-Tyr-Arg-Tyr-Tyr-Glu-Tyr-Lys-Phe- 
rSS--l 170 
Gln-Val-Cys-Val-Gly-Ser-Pro-Thr-Thr-Leu-Arg-Ala-Ala-Phe-f~et- 
180 l 190 
Gly-Asp-SER-Gly-Gly-Pro-Leu-Leu-Cys-Ala-Gly-Val-Ala-His-Gly- 
200 
Ile-Val-Ser-Tyr-Gly-His-Pro-Asp-Ala-Lys-Pro-Pro-Ala-Ile-Phe- 
210 220 
Thr-Arg-Val-Ser-Thr-Tyr-Val-Pro-Thr-Ile-Asn-Ala-Val-Ile-Asn 
Fig.1. The covalent structure of RMCP II. Residue of the 
‘charge-relay’ system of the active site are in capital letters 
(HIS45, ASP-89, and SER-182). (*) indicates the location 
that radioactivity was observed when the protease was 
inactivated with [‘%]DFP. The disulfide bonds are indicated 
as -SS-. 
(2) 
participates in the primary substrate binding site 
in serine proteases; i.e., Asp-177 in trypsin, Ser- 
189 in chymotrypsin. Thus, this binding site in 
the mast cell protease is less polar than that of 
any of the known serine proteases. 
Three disulfide bonds are present in the mast 
cell protease as compared to five in chymo- 
trypsin, six in trypsin and four in elastase. The 
mast cell enzyme uniquely lacks a disulfide bond 
which is present in all known serine proteases 
(fig.2) and links Cys-19 1 to Cys-220 in chymo- 
trypsin. In view of the close proximity of this 
bond to both the primary and antiparallel bind- 
ing sites [38] of other serine proteases, it is likely 
that its absence in the atypical mast cell protease 
is related to the substrate specificity of this 
enzyme. 
191 
Volume 114, number 2 
224 240 
FEBS LETTERS June 1980 
tural features of the enzyme relate to its activity and 
specificity. 
ELASTASE 
Fig.2. Comparison of the location of the disulfide bonds (m) 
in RMCP II and pancreatic elastase. Active site residues are 
indicated (0). Arrows indicate the disulfide bond present in 
all known serine proteases except RMCP II. 
Analysis of the 3-dimensional structure of RMCP II is 
now being carried out by Matthews and coworkers at 
the University of Oregon and when completed should 
provide important information as to how these struc- 
A comparison of the 52 amino-terminal residues of 
the normal mast cell proteases with those of the atyp- 
ical mast cell protease and of bovine chymotrypsin A 
(fig.3) shows -75% sequence identity between the 
mast cell enzymes and -40% compared to bovine 
chymotrypsin A [28]. Since the structures of the 
catalytic and substrate binding regions of the normal 
mast cell protease (RMCP I) have not been deter- 
mined, no comparison can be made yet in regard to 
how structural differences between the two mast cell 
proteases may relate to known differences in their 
activities [ 191. 
RMCP lI 
Muscle Protease 
1 10 20 
Ile-Ile-Gly-Gly-Val-Glu-Ser-Arg-Pro-His-Ser-Arg-Pro-Tyr-~~et-Ala-His-Leu-Glu-Ile-Thr- 
Mast Cell Protease Ile-Ile-Gly-Gly-Val-Glu-Ser-Arg~Pro-His-Ser-Arg-Pro-Tyr-Met-Ala-His-Leu-Glu-Ile-Thr- 
Atypical Mast Cell 
Protease 
Bovine Chymotrypsin 
Ile-Ile-Gly-Gly-Val-Glu-Se Pro-His-Ser-Arg-Pro-Tyr-Met-Ala-His-Leu 
Ile-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-Trp-Pro-Trp-Gln-Val-Ser-Leu-Gln-Asp-Lys- 
- - - - - - - 
Muscle Protease 
Mast Cell Protease Thr-Glu-Arg-Gly-Tyr-Lys-Ala-Thr-Cys-Gly-Gly-Phe-Leu-Val 
Atypical Mast Cell 
Protease 
Bovine Chymotrypsin 
Cys-Gly-Gly-Phe-Leu 
Thr-Gly-Phe-------------His-Phe-Cys-Gly-Gly-Ser-Leu-Ile-Asn-Glu-Asn-Trp-Val-Val-Thr- 
----- 
Muscle Protease 
Atypical Mast Cell 
Protease 
Bovine Chymotrypsin Ala-Ala-His-Cys-Gly-Val-Thr-Thr-Ser- 
Since insertions and deletions (gaps) of residues in 
the sequences of homologous proteins occur less 
frequently than amino acid substitutions [39], the 
evolutionary relationship of homologous proteins 
Fig.3. Comparison of the amino-terminal sequences of rat normal mast cell protease (RMCP I), atypical mast cell protease (RMCP 
II), and bovine chymotrypsin A. Muscle protease is normal mast cell protease. (---) indicates a gap placed in the sequence of 
chymotrypsin in order to obtain an optimal alignment of this structure with the others. Residues of chymotrypsin that are under- 
lined are identical to those in mast cell protease. 
192 
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THE EVOLUTIONARY RELATIONSHIP OF MAMMALIAN 
SERINE PROTEASES 
ANCESTRAL SERINE PROTEASE 
Fig.4. The evolutionary relationship of the serine proteases as 
determined by the number of insertions and deletions (gaps) 
arising from optimally aligned sequences of the enzymes. 
Numbers indicate the sequence gaps occurring when the struc- 
tures are compared. Points of divergence are indicated (a). 
may be more reliably estimated from the number and 
position of inferred gaps arising when the sequences 
are optimally aligned [40]. Based on this criterion, 
the progenitor of atypical mast cell protease may 
have arisen sometime after that of trypsin but before 
those of elastase and chymotrypsin (fig.4) [37]. 
Examination of the amino acid compositions of the 
two mast cell enzymes shows that the protease from 
normal mast cell contains twice as much lysine as 
does the enzyme from the atypical cell. The former 
enzyme binds strongly to the highly sulfated acid 
mucopolysaccharide, heparin, present in mast cell 
granules and requires high salt concentrations (1 M 
KCl) to disassociate the complex. In contrast, RMCP 
II is freely extracted from granules without any 
added salt. The solubility differences of the two 
enzymes may well be explained by their levels of 
lysine . 
No sequence information has been reported yet 
for the human neutrophil proteases. Human cathepsin 
G and normal rat mast cell protease have a number of 
properties in common, including the requirement of 
high salt solutions to maintain solubility, chymo- 
trypsin-like esterase activity, similar molecular weights, 
location in secretory granules, the apparent lack of a 
zymogen precursor, in situ association with sulfated 
acid mucopolysaccharides, basic isoelectric points, as 
well as the fact that each is synthesized by cells 
believed to play major roles in inflammation. Indeed, 
Starkey [41] has suggested that cathepsin G and mast 
cell protease (chymase) represent the same enzyme in 
different cells. This question will remain unanswered 
until the human mast cell proteases are characterized. 
It was concluded from the results of immunofluo- 
rescent studies in the rat, however, that neutrophils 
do not contain a protease which is antigenically similar 
to mast cell protease [26]. Nevertheless, human 
cathepsin G and rat normal mast cell protease are sim- 
ilar enough in chemical, physical and enzymatic prop- 
erties to suggest hat perhaps they do carry out a 
similar function during inflammation, but are triggered 
by different cellular mechanisms. 
5. Specificity 
Both RMCP I and RMCP II have chymotrypsin- 
like esterase activity. The activities of RMCP I @mol 
substrate hydrolyzed . min-’ . mg enzyme-’ ) toward 
AcTyrOEt and BzTyrOEt are 3-lo-fold higher, res- 
pectively, as compared to RMCP II. The esterase 
activity of RMCP I is comparable to that of bovine 
chymotrypsin. 
Powers and coworkers at the Georgia Institute of 
Technology are investigating in detail the substrate 
specificity of the two mast cell proteases toward syn- 
thetic polypeptide derivatives of p-nitroanilide (in 
preparation). Their results indicate that the mast 
cell enzymes possess proteolytic activity which 
appears unique among the known serine proteases and 
their findings should be helpful in defining the struc- 
ture-function relationships of these proteases. The 
best substrates for both mast cell proteases have the 
general structure: 
P4 P3 P2 Pl 
I I I I 
X-Y-Let.-PheJ-p-nitroanilide 
where the bond cleaved is indicated by the arrow and 
the designation for the ammo acid residue position, 
e.g. Pl , is that of Schechter and Berger [42]. This 
observation is consistent with those of Kobayashi et 
al. [43,44] who observed similar specificity require- 
ments. Chloromethyl ketone derivatives of the same 
general structure were found to be the most effective 
inhibitors of mast cell proteases. The best substrates 
for both proteases were N-Suc-Phe-Ieu-Phe-p- 
nitroanilide and N-Sue-Phe-Pro-Phe-p-nitroanilide. 
The specificity constant ke.JKrn for RMCP I, how- 
ever, is -loo-times greater than that for RMCP II. 
193 
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Katunuma et aI. [19] observed that RMCP I was 
-loo-times more efficient than RMCP II in inacti- 
vating ornithine amino transferase. The pH optimum 
for the hydrolysis of both synthetic substrates by the 
atypical mast cell protease was 6.6. Compared to the 
values measured at pH 8.0, kcat was ‘/z as great and 
Km only l/lOth as great at pH 6.6 resulting in a 5- 
fold increase in /cat/Km. Examination of the amino 
acid sequence of atypical mast cell protease shows 
that there is a histidyl residue at position 200 which 
may interact with the succinyl group at P4 of the sub- 
strate. An interaction of this type would explain the 
unusual pH profile for these substrates. Perhaps the 
most interesting observation made during this study 
was that polypeptides containing a prolyl residue at Ps 
were excellent substrates for both mast cell proteases. 
These types of substrates are not cleaved by other 
serine proteases in a way which releases p-nitroaniline 
[44,45]. For example, RMCP II catalyzes the release 
of p-nitroanilide from N-Suc-Ala-Pro-Leu-Phe-p- 
nitroanilide with a kcat/Km of 2100 M-l. s-l. Cathep- 
sin G or chymotrypsin will not release p-nitroaniline 
from this substrate but the former protease will cleave 
the Leu-Phe bond with a kcat/Km of 8.9 M-l. s-‘. 
Apparently, most serine proteases cannot accommo- 
date a prolyl residue at position Pa at the antiparallel 
binding site of the enzyme and at the same time allow 
the Pr residue to fit correctly into the primary sub- 
strate binding site [44]. If possible, the enzyme will 
interact with the substrate in a way which places the 
prolyl residue at position PZ with respect to the bond 
cleaved. The reason that the mast cell enzymes can 
accept a Pa prolyl residue in the substrate may well 
be related to the unique structural feature in the 
vicinity of the substrate binding site which has already 
been discussed. 
The efficiency of RMCP I as a protease, based on 
the observed activity toward N-Suc-Phe-Ieu-Phe- 
p-nitroanilide is quite remarkable. Cathepsin G cleaves 
this substrate readily to yield free p-nitroaniline with 
a &t/K, of 1500 M-’ . s-l, whereas the specificity 
constant for RMCP II is - 18 000 M-r . s-l. Under 
identical conditions, the kcat/Km for RMCP I is 
-1 X lo6 M-l. s-l, one of the highest specificity con- 
stants recorded for any protease/synthetic substrate 
system tested! 
6. Physiologic role 
Mast cells are important mediators of allergic, 
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infective and anaphylactic reactions of tissues in most 
animals. The secretory granules of these cells contain 
histamine and/or serotonin or other vasoactive amines 
in addition to proteases. It has been widely assumed 
that the proteases contribute to the inflammatory 
process by degrading ground substances or by causing 
lesions in the vascular bed [47]. In view of the close 
proximity of mast cells to blood lymphatic vessels in 
tissues, it has been suggested that the mast cell 
enzymes promote and intensify the increase in vascu- 
lar permeability initiated by the action of histamine 
[48]. Indeed, a recent study has shown that RMCP I 
when injected into rats leads to a very rapid increase 
in vascular permeability [49]. There is no function, 
however, which has been shown conclusively to be 
due to the action of mast cell proteases. 
Because of the similar specificities of the two mast 
cell proteases toward synthetic peptides and peptide 
hormones (J. C. Powers and N. Yoshita, unpublished; 
[43,44]) one is tempted to suggest hat each enzyme 
carries out similar functions and that the differences 
between the proteases reflect tissue specificity. There 
is no evidence whatsoever that this is so. Indeed, 
accumulated data strongly indicate that the so-called 
atypical mast cells are, in fact, unrelated to normal 
mast cells with the exception that both contain baso- 
philic granules rich in chymotrypsin-like protease. 
The current view is that the atypical mast cells in 
mammals (including man) are somehow involved in 
the local immune or inflammatory response at 
mucosal surfaces, particularly in parasitic infections 
[50-521. Miller and Jarrett [50] observed that in gut 
these cells increased at least lo-fold at the time when 
rats spontaneously expelled nematodes from this site. 
In a recent quantitative study of the levels of protease 
during nematode infection (R. G. Woodbury and 
H. R. P. Miller, unpublished), it was observed that a 
similar increase in enzyme level accompanies the 
increase in the number of atypical mast cells. Recent 
evidence suggests that the occurrence of the atypical 
mast cells, but not normal mast cells, is dependent on 
T-lymphocytes [53,54]. Kitamura et al. [54] have 
shown that atypical mast cells of mouse small intes- 
tine, but not normal mast cells, arise from precursor 
cells derived from bone marrow. These observations, 
together with the morphologic [55] and histologic 
[56] differences between atypical and normal mast 
cells strongly suggest hat the cells are distinct types. 
There is suggestive vidence that atypical mast cells 
are involved in the local immune response at the 
Volume 114, number 2 FEBS LETTERS June 1980 
mucosal surface since it was observed that during the 
development of rats there is a significant proliferation 
of these cells and an increase in the protease levels 
precisely at the same time that the levels of I,A of the 
gut are synthesized in measurable quantities [27]. 
Recently, it was observed that Rh4CP I, but not 
RIvlCP II, efficiently produces limited proteolysis of 
native human placenta type IV collagen which was 
obtained by mild treatment with pepsin [57]. Type I 
collagen was resistant to the action of both enzymes. 
If type IV collagen was prepared without pepsin treat- 
ment however, RMCP II cleaved native collagen, 
resulting in a product which had a molecular weight 
similar to pepsin-treated type IV collagen. Since type 
IV collagen is a major component of ‘basement mem- 
branes’ which underlie epithelial and endothelial cells 
and since both types of mast cells are in close proxim- 
ity to these structures, it would appear that exami- 
nations of the effect of mast cell proteases on native 
basement membrane collagen would be worthy of 
further study. 
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